Summary of 2012/13 QOF Changes

Similar documents
Summary of 2011/12 QOF indicator changes, points and thresholds

17/18 Threshold 18/19 Points 18/19. Points NO CHANGE NO CHANGE NO CHANGE

SUMMARY OF CHANGES TO QOF 2017/18 - ENGLAND CLINICAL

14/15 Threshold 15/16 Points 15/16. Points. Retired Replaced by NM82/AF007. Replacement NO CHANGE

SUMMARY OF CHANGES TO QOF 2014/15 - ENGLAND CLINICAL

New indicators to be added to the NICE menu for the QOF and amendments to existing indicators

POTENTIAL LINKAGES BETWEEN THE QUALITY AND OUTCOMES FRAMEWORK (QOF) AND THE NHS HEALTH CHECK

The contractor establishes and maintains a register of patients with AF

12/13 Threshold. 13/14 Points. 12/13 Points. Minor wording change (noted in bold) mnth change

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE QUALITY AND OUTCOMES FRAMEWORK (QOF) INDICATOR DEVELOPMENT PROGRAMME. Indicator Assessment Report

Scottish Quality and Outcomes Framework 2013/2014. Guidance for NHS Boards and GP practices

2. Quality and Outcomes Framework: new NICE recommendations

Quality And Outcomes Framework Guidance for the GMS Contract Wales 2018/19. June 2018

Scottish Quality and Outcomes Framework guidance for GMS contract 2015/16

2015/16 General Medical Services (GMS) contract Quality and Outcomes Framework (QOF)

Quality and Outcomes Framework guidance for GMS contract 2009/10. Delivering investment in general practice

Quality And Outcomes Framework Guidance for the GMS Contract Wales 2013/14. May 2013

Royal Crescent Surgery

Cardiology The interface between Primary and Secondary Care

The following principles relating to the Quality and Outcomes Framework (QOF) were agreed by the negotiators.

Quality And Outcomes Framework Guidance for the GMS Contract Wales 2014/15. June 2014

QOF (England): clinical indicators

Ref. No. Title Quality Dimension

Working with the changes to QoF 08/09

Physical Health Checks

Four Years of NHS Health Checks in Barnsley - Outcomes and Inequalities

GUIDE TO CODING AND DISEASE REGISTERS FOR THE CONTRACT (Scottish) Version 1.0. January 2014

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE General practice Indicators for the NICE menu

GUIDE TO CODING AND DISEASE REGISTERS FOR THE CONTRACT (Scottish) Version 1.0

Indicator Points Payment stages. HF 1: The practice can produce a register of patients with 4 heart failure

NICE Indicator Programme. Consultation on proposed amendments to current QOF indicators

Vascular checks a vascular risk assessment and management. Heather White Deputy Branch Head Vascular Programme

National Primary Care Research and Development Centre and University of York Health Economics Consortium (NICE External Contractor)

Atrial Fibrillation. A guide for Southwark General Practice. Key Messages. Always work within your knowledge and competency

GP Insight Report. The Family Practice CQC ID:

CQC Insight. NHS GP practices Indicators and methodology

GP Insight Report. Oaklands CQC ID:

Improving physical health for people with mental health conditions in primary care

Coronary Heart Disease

Optimising Hypertension Management Clair Huckerby Pharmaceutical Adviser- Medicines Optimisation Lead

Commissioning for value focus pack

Atrial Fibrillation Implementation challenges. Lesley Edgar Ross Maconachie

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

Delivering effective physical health checks in practice. Dr Sheila Hardy, Education Fellow, UCLPartners and Honorary Senior Lecturer, UCL 9.12.

Community network profile Herne Bay

What s new in cardiovascular disease risk assessment and management for primary care clinicians

Quality and Outcomes Framework Programme NICE cost impact statement July Indicator area: Osteoporosis - fragility fracture

New PINNACLE Measures The below measures for PINNACLE will be added as new measures to the outcomes reporting starting with Version 2.0.

Quality Payment Program: Cardiology Specialty Measure Set

SECONDARY PREVENTION OF CORONARY HEART DISEASE AND ISCHAEMIC STROKE/TIA

2 Summary of NICE TA 249: Atrial fibrillation - Dabigatran Etexilate

HERTFORDSHIRE MEDICINES MANAGEMENT COMMITTEE (HMMC) DABIGATRAN RECOMMENDED What it is Indications Date decision last revised

Rhona Maclean

E-portfolio guide. This guide will take you through, step by step, the type of information we expect you to record at each stage of your cycle.

Outcomes of diabetes care in England and Wales. A summary of findings from the National Diabetes Audit : Complications and Mortality reports

CV Update Guidelines & Debates Royal Pharmaceutical Society, Great Britain Barnet 27/01/09

Time Series Analysis for selected clinical indicators from the Quality and Outcomes Framework

Adult Pre Participation Screening and Exercise Prescription Practicum

OCCG SERVICE SPECIFICATION (2018/19) Improving Physical Health in Patients with a Severe Mental Illness

Trends and Variations in General Medical Services Indicators for Coronary Heart Disease: Analysis of QRESEARCH Data

Measurement Name Beta-Blocker Therapy Prior Myocardial Infarction (MI)

Quality Payment Program: Cardiology Specialty Measure Set

GOVERNING BODY REPORT

Module 2. Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension

Guidelines to assist General Practitioners in the Management of Type 2 Diabetes. April 2010

How a universal health system reduces inequalities: lessons from England

Hypertension Clinical case scenarios for primary care

Manitoba Primary Care Quality Indicators Full Guide Version 3.0 Quick Reference Summary

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

Program Metrics. New Unique ID. Old Unique ID. Metric Set Metric Name Description. Old Metric Name

Lucia Cea Soriano 1, Saga Johansson 2, Bergur Stefansson 2 and Luis A García Rodríguez 1*

APPLICATION FORM CHRONIC MEDICINE BENEFIT 2019

New Guidelines in Dyslipidemia Management

IMPROVING BONE HEALTH AND FRACTURE PREVENTION

CCG data collection for people with severe mental illness receiving a full physical health check and follow-up interventions in primary care

Prescribed Minimum Benefits treatment guidelines 2013

NHS QIS National Measurement of Audit Acute Coronary Syndrome

2016 Internal Medicine Preferred Specialty Measure Set

Younger adults with a family history of premature artherosclerotic disease should have their cardiovascular risk factors measured.

Cardiff East Cluster

5.2 Key priorities for implementation

Supplementary Appendix

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE QUALITY AND OUTCOMES FRAMEWORK (QOF) INDICATOR DEVELOPMENT PROGRAMME

Appendix This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors.

Practice-Level Executive Summary Report

th Street, NW Suite 1000 Washington, DC phone fax

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

GRASP-AF- The National Picture. Dr Richard Healicon National Improvement Lead Ian Robson Senior Analyst NHS Improvement February 2012

Stroke secondary prevention. Gill Cluckie Stroke Nurse Consultant St. George s Hospital

Management of Hypertension. Ahmed El Hawary MD Suez Canal University

Patient is healthy with no chronic disease or significant risk factors [16%].

2016 General Practice/Family Practice Preferred Specialty Measure Set

Coronary Heart Disease and Stroke, Primary and Secondary Prevention Guidelines (Cholesterol)

th Street, NW Suite 1000 Washington, DC phone fax

NHFD Chester Feb 3 rd 2010

Preventing Cardiovascular Disease Stroke Primary Prevention Guidelines. John Potter Professor Ageing & Stroke Medicine University of East Anglia

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

Swindon Diabetes Guidelines: Management of Chronic Kidney Disease Associated with Diabetes Mellitus

MPharmProgramme. Hypertension (HTN)

FINANCE COMMITTEE DEMOGRAPHIC CHANGE AND AGEING POPULATION INQUIRY SUBMISSION FROM NATIONAL OSTEOPOROSIS SOCIETY

Transcription:

Summary of QOF Changes Retirements 2011/12 CHD13 AF4 QP1 QP2 QP3 QP4 QP5 2011/12 Indicator Wording Threshold For patients with newly diagnosed angina (diagnosed after 1 April 2011), the percentage who are referred for specialist assessment The percentage of patients with atrial fibrillation diagnosed after 1 April 2008 with ECG or specialist confirmed diagnosis The practice conducts an internal review of their prescribing to assess whether it is clinically appropriate and cost effective, agrees with the PCO 3 areas for improvement and produces a draft plan for each area no later than 30 June 2011 The practice participates in an external peer review of prescribing with a group of practices and agrees plans for 3 prescribing areas for improvement firstly with the group and then with the PCO no later than 30 September 2011 The percentage of prescriptions complying with the agreed plan for the first improvement area as a percentage of all prescriptions in that improvement area during the period 1 January 2012 to 31 March 2012 (Payment stages to be determined locally according to the method set out in the indicator guidance below with 20 percentage points between upper and lower thresholds) The percentage of prescriptions complying with the agreed plan for the second improvement area as a percentage of all prescriptions in that improvement area during the period 1 January 2012 to 31 March 2012 (Payment stages to be determined locally according to the method set out in the indicator guidance below with 20 percentage points between upper and lower thresholds) The percentage of prescriptions complying with the agreed plan for the third improvement area as a percentage of all prescriptions in that improvement area during the period 1 January 2012 to 31 March 2012 (Payment stages to be determined locally according to the method set out in the indicator guidance below with 20 percentage points between upper and lower thresholds) 7 40-90 10 40-90 6-7 - 5 Locally determined 5 Locally determined 5 Locally determined Page 1 of 6

Replacement Indicators indicator wording amendments 2011/12 NICE ID Indicator Wording Threshold Asthma6 NM23 Asthma9 The percentage of patients with asthma who have had an asthma review in the preceding 15 months that includes an assessment of asthma control using the 3 RCP questions Smoking3 NM38 Smoking5 The percentage of patients with any or any combination of the following conditions: CHD, PAD, stroke or TIA, hypertension, diabetes, COPD, CKD, asthma, schizophrenia, bipolar affective disorder or other psychoses whose notes record smoking status in the preceding 15 months Smoking4 NM39 Smoking6 The percentage of patients with any or any combination of the following conditions: CHD, PAD, stroke or TIA, hypertension, diabetes, COPD, CKD, asthma, schizophrenia, bipolar affective disorder or other psychoses who smoke whose notes contain a record that smoking cessation advice or referral to a specialist service, where available, has been offered within the preceding 15 months DM19 NM41 DM32 The practice can produce a register of all patients aged 17 years and over with diabetes mellitus, which specifies the type of diabetes where a diagnosis has been confirmed MH15 NM42 MH20 The percentage of patients aged 40 years and over with schizophrenia, bipolar affective disorder and other psychoses who have a record of blood glucose or HbA1c in the preceding15 months AF3 NM45 AF6 In those patients with Atrial Fibrillation in whom there is a record of a CHADS2 score of 1, the percentage of patients who are currently treated with anti-coagulation drug therapy or an anti-platelet therapy. AF3 NM46 AF7 In those patients with Atrial Fibrillation in whom there is a record of a CHADS2 score of greater than 1, the percentage of patients who are currently treated with anti-coagulation drug therapy DEM3 - DEM4 The percentage of patients with a new diagnosis of dementia recorded between the preceding 1 April to 31 March with a record of FBC, calcium, glucose, renal and liver function, thyroid function tests, serum vitamin B12 Page 2 of 6 20 45-70 25* 50-90 25* 50-90 6 n/a 5 45-80 6 50-90 6 40-70 6 45-80

and folate levels recorded 6 months before or after entering on to the register DEP5 - DEP8 In those patients with a new diagnosis of depression and assessment of severity recorded between the preceding 1 April to 31 March, the percentage of patients who have had a further assessment of severity 2-12 weeks (inclusive) after the initial recording of the assessment of severity. Both assessments should be completed using an assessment tool validated for use in primary care Education 1 - Eduction11 There is a record of all practice-employed clinical staff and clinical partners having attended training/updating in basic life support skills in the preceding 18 months. * reduced from 2011/12 to Smoking5 reduced by 5 points and Smoking6 reduced by 5 points 8 45-80 4 - Replacement Indicators changed due to noteworthy coding or business logic amendments 2011/12 NICE ID 2011/12 Indicator Wording Threshold MH14 - MH19 The percentage of patients aged 40 years and over with schizophrenia, bipolar affective disorder and other psychoses who have a record of total cholesterol:hdl ratio in the preceding 15 months Asthma3 - Asthma10 The percentage of patients with asthma between the ages of 14 and 19 years in whom there is a record of smoking status in the preceding 15 months DEP1 - DEP6 The percentage of patients on the diabetes register and/or the CHD register for whom case finding for depression has been undertaken on 1 occasion during the preceding 15 months using two standard screening questions DEP4 - DEP7 In those patients with a new diagnosis of depression, recorded between the preceding 1 April to 31 March, the percentage of patients who have had an assessment of severity at the time of diagnosis using an assessment tool validated for use in primary care Page 3 of 6 5 45-80 6 45-80 6 50-90 17 50-90

Records23 - Smoking7 The percentage of patients aged 15 years and over whose notes record smoking status in the preceding 27 months (Note: indicator also moved to clinical domain) Note: All final QOF indicator ID numbers are still subject to change as national guidance and supporting business rules are finalised. 11 50-90 New Indicators NICE ID Indicator Wording Threshold NM32 PAD1 The practice can produce a register of people with peripheral arterial disease 2 - NM33 PAD2 The percentage of patients with peripheral arterial disease with a record in the 2 40-90 preceding 15 months that aspirin or an alternative anti-platelet is being taken NM34 PAD3 The percentage of patients with peripheral arterial disease in whom the last blood 2 40-90 pressure reading (measured in the preceding 15 months) is 150/90 or less NM35 PAD4 The percentage of patients with peripheral arterial disease in whom the last 3 40-90 measured total cholesterol (measured in preceding 15 months) is 5.0mmol/l or less NM24 AF5 The percentage of patients with Atrial Fibrillation in whom stroke risk has been assessed using the CHADS2 risk stratification scoring system in the preceding 15 months 10 40-90 NM40 Smoking8 The percentage of patients aged 15 years and over who are recorded as current smokers who have a record of an offer of support and treatment within the preceding 27 months NM29 OST1 The practice can produce a register of patients: 1. Aged 50-74 years with a record of a fragility fracture after 1 April 2012 and a diagnosis of osteoporosis confirmed on DXA scan, and 2. Aged 75 years and over with a record of a fragility fracture after 1 April 2012 NM30 OST2 The percentage of patients aged between 50 and 74 years, with a fragility fracture, in whom osteoporosis is confirmed on DXA scan, who are currently treated with an appropriate bone-sparing agent NM31 OST3 The percentage of patients aged 75 years and over with a fragility fracture, who are currently treated with an appropriate bone-sparing agent 12 40-90 3 30-60 3 30-60 3 30-60 Page 4 of 6

- QP12 The practice meets internally to review the data on accident and emergency attendances provided by the PCO no later than 31 July 2012. The review will include consideration of whether access to clinicians in the practice is appropriate, in light of the patterns on accident and emergency attendance. - QP13 The practice participates in an external peer review with a group of practices to compare its data on accident and emergency attendances, either with practices in the group of practices or practices in the PCO area and agrees an improvement plan firstly with the group and then with the PCO no later than 30 September 2012. The review should include, if appropriate, proposals for improvement to access arrangements in the practice in order to reduce avoidable A&E attendances and may also include proposals for commissioning or service design improvements to the PCO. - QP14 The practice implements the improvement plan that aims to reduce avoidable accident and emergency attendances and produces a report of the action taken to the PCO no later than 31 March 2013 7-9 - 15 - Reduced points change only in point value 2011/12 Indicator Wording BP4 BP4 The percentage of patients with hypertension in whom there is a record of the blood pressure in the preceding 9 months BP5 BP5 The percentage of patients with hypertension in whom the last blood pressure (measured in the preceding 9 months) is 150/90 or less DM2 DM2 The percentage of patients with diabetes whose notes record BMI in the preceding 15 months DM22 DM22 The percentage of patients with diabetes who have a record of estimated glomerular filtration rate (egfr) or serum creatinine testing in the preceding 15 months CKD2 CKD2 The percentage of patients on the CKD register whose notes have a record of blood pressure in the preceding 15 months 2011/12 Threshold 16 8 50-90 57 55 45-80 3 1 50-90 3 1 50-90 6 4 50-90 Page 5 of 6

Increased thresholds For the following indicators, the thresholds have changed from 40-90 to 50-90: CHD9, CHD12, HF2, Stroke7, Stroke12, BP4, DM2, DM10, DM13, DM21, DM22, DM28, DM29, Epilepsy6, Epilepsy9, Thyroid 2, Cancer3, MH11, MH12, MH13, MH17, MH18, DEP6, DEP7, CKD2, AF6, Smoking5, Smoking6, Smoking7, SH2 and SH3 For the following indicators, where the upper threshold is between 70 to 85 the lower threshold has changed from 40 to 45: CHD8, CHD14, HF3, Stoke13, Stroke10, DM27, DM30, DM15, DM18, COPD15, COPD8, Epilepsy8, MH19, MH20, MH16, Asthma8, Asthma3, Asthma9, DEM4, DEP8, CKD3, CKD5, CKD6, LD2, CS1 For the following indicators, the upper thresholds have changed as follows: 2011/12 2011/12 CHD6 17 40-71 40-75 Stroke6 5 40-71 40-75 CHD10 7 40-60 40-65 Stroke8 5 40-60 40-65 CVD-PP1 8 40-70 40-75 DM31 3 40-60 40-65 CVD-PP2 5 40-70 40-75 DM17 6 40-70 40-75 HF4 9 40-60 40-65 COPD10 7 40-70 40-75 For the following indicators, the lower and upper thresholds have changed as follows: 2011/12 2011/12 BP5 55 40-70 45-80 DEM2 15 25-60 35-70 MH10 6 25-50 30-55 QOF Guidance The detailed QOF guidance will be published in due course. Page 6 of 6